As Glaxosmithkline Plc (GSK) Stock Rose, 10-15 Associates Has Lifted Its Stake by $922,080; Mckesson (MCK) Holding Has Lifted by Pzena Investment Management Llc

February 22, 2018 - By Darrin Black

Richard S. Pzena increased its stake in Mckesson Corporation (MCK) by 17.19% based on its latest 2017Q3 regulatory filing with the SEC. Pzena Investment Management Llc bought 360,676 shares as the company’s stock rose 1.84% with the market. The hedge fund run by Richard S. Pzena held 2.46M shares of the other pharmaceuticals company at the end of 2017Q3, valued at $377.66M, up from 2.10 million at the end of the previous reported quarter. Pzena Investment Management Llc who had been investing in Mckesson Corporation for a number of months, seems to be bullish on the $30.99B market cap company. The stock increased 0.41% or $0.61 during the last trading session, reaching $150.2. About 717,288 shares traded. McKesson Corporation (NYSE:MCK) has declined 15.45% since February 22, 2017 and is downtrending. It has underperformed by 32.15% the S&P500.

10-15 Associates Inc increased its stake in Glaxosmithkline Plc (GSK) by 9.59% based on its latest 2017Q3 regulatory filing with the SEC. 10-15 Associates Inc bought 23,052 shares as the company’s stock rose 5.47% with the market. The institutional investor held 263,345 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $10.69M, up from 240,293 at the end of the previous reported quarter. 10-15 Associates Inc who had been investing in Glaxosmithkline Plc for a number of months, seems to be bullish on the $81.10 billion market cap company. The stock increased 0.25% or $0.0914 during the last trading session, reaching $36.6529. About 1.78M shares traded. GlaxoSmithKline plc (NYSE:GSK) has risen 4.26% since February 22, 2017 and is uptrending. It has underperformed by 12.44% the S&P500.




10-15 Associates Inc, which manages about $592.54 million and $395.85 million US Long portfolio, decreased its stake in Boeing Co (NYSE:BA) by 4,296 shares to 41,082 shares, valued at $10.44M in 2017Q3, according to the filing.

Among 18 analysts covering GlaxoSmithKline (NYSE:GSK), 8 have Buy rating, 1 Sell and 9 Hold. Therefore 44% are positive. GlaxoSmithKline had 28 analyst reports since September 8, 2015 according to SRatingsIntel. The stock of GlaxoSmithKline plc (NYSE:GSK) earned “Hold” rating by Cowen & Co on Monday, December 11. The stock of GlaxoSmithKline plc (NYSE:GSK) has “Underweight” rating given on Friday, September 8 by Morgan Stanley. The stock of GlaxoSmithKline plc (NYSE:GSK) earned “Neutral” rating by JP Morgan on Wednesday, April 26. The rating was upgraded by Bryan Garnier & Cie to “Buy” on Wednesday, January 27. The rating was upgraded by Berenberg to “Buy” on Friday, May 26. Piperjaffray initiated the stock with “Overweight” rating in Friday, September 23 report. BNP Paribas downgraded the shares of GSK in report on Wednesday, September 14 to “Underperform” rating. Bank of America upgraded the shares of GSK in report on Wednesday, December 9 to “Buy” rating. The company was maintained on Friday, June 16 by J P Morgan Chase Co. The stock of GlaxoSmithKline plc (NYSE:GSK) has “Hold” rating given on Thursday, October 26 by Bank of America.

Investors sentiment decreased to 0.88 in Q3 2017. Its down 0.07, from 0.95 in 2017Q2. It is negative, as 65 investors sold MCK shares while 296 reduced holdings. 72 funds opened positions while 246 raised stakes. 180.04 million shares or 2.23% more from 176.11 million shares in 2017Q2 were reported. Busey Tru holds 0.5% or 27,260 shares in its portfolio. Royal Retail Bank Of Canada reported 502,480 shares stake. Mitsubishi Ufj Tru And has invested 0.12% of its portfolio in McKesson Corporation (NYSE:MCK). Exane Derivatives invested in 0% or 90 shares. Manchester Cap Mngmt Llc accumulated 0.02% or 688 shares. Schroder Invest Mgmt Grp Inc reported 0.12% in McKesson Corporation (NYSE:MCK). Hexavest holds 0.8% of its portfolio in McKesson Corporation (NYSE:MCK) for 425,264 shares. 910 are held by Vestor Ltd Co. Mackenzie Fin Corp stated it has 0.46% in McKesson Corporation (NYSE:MCK). Clark Estates Ny holds 0.57% or 22,500 shares in its portfolio. Gideon Capital Advsr holds 0.22% or 1,430 shares in its portfolio. Regions Fin invested in 21,768 shares or 0.04% of the stock. Atwood & Palmer Incorporated accumulated 1,000 shares or 0.02% of the stock. Moreover, D E Shaw And Comm has 0.11% invested in McKesson Corporation (NYSE:MCK). Ruffer Limited Liability Partnership owns 9.38% invested in McKesson Corporation (NYSE:MCK) for 1.42 million shares.

Since September 7, 2017, it had 0 insider buys, and 5 selling transactions for $121.68 million activity. 900 shares were sold by Lampert Erin M, worth $140,089.

Pzena Investment Management Llc, which manages about $24.64 billion and $18.92 billion US Long portfolio, decreased its stake in Willis Towers Watson Plc by 65,998 shares to 1.26 million shares, valued at $194.80 million in 2017Q3, according to the filing. It also reduced its holding in Xl Group Ltd by 62,218 shares in the quarter, leaving it with 5.14M shares, and cut its stake in Kbr Inc (NYSE:KBR).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts